Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Adults aged 18 or older
Men, or women who are not pregnant
People who have had an acute coronary syndrome (a sudden, serious heart condition such as a heart attack) and need a procedure called PCI, which opens blocked heart arteries using a small balloon and often a stent
People for whom heart bypass surgery (a different type of heart operation) is not ruled out
People considered to be at high risk of bleeding, based on a specific medical scoring system — this means meeting at least one "major" or two "minor" risk factors from the lists below:
Major bleeding risk factors include:
- Needing long-term blood thinning tablets
- Severely reduced kidney function
- Moderate to severe low red blood cell levels (anaemia)
- A serious bleeding episode requiring a hospital stay or blood transfusion within the past 6 months, or repeated bleeding episodes
- A long-term condition that causes abnormal bleeding
- A very low platelet count (platelets help blood clot) before the procedure
- Liver cirrhosis with high pressure in the liver's blood vessels
- A diagnosis or treatment for cancer (other than certain skin cancers) in the past 12 months
- A history of bleeding inside the brain that happened on its own
- Bleeding inside the brain caused by injury within the past 12 months
- A known abnormal tangle of blood vessels in the brain
- A moderate to severe stroke caused by reduced blood flow within the past 6 months
- Major surgery or serious physical trauma within the 30 days before the procedure
- Major surgery that cannot be postponed, planned during the period when dual blood-thinning medication would be needed
Minor bleeding risk factors include:
- Age 75 or older
- Mildly to moderately reduced kidney function
- Mild anaemia (low red blood cell levels)
- A serious bleeding episode requiring hospital care between 6 and 12 months before the procedure
- Ongoing use of anti-inflammatory pain medicines (such as ibuprofen) or steroids after the procedure
- A stroke caused by reduced blood flow that occurred more than 6 months before the procedure
People who are able to understand the goals of the trial and agree to participate by signing a consent form
Based on the heart artery images (angiographic criteria), people may also need to meet these conditions:
- The main artery being treated must be a natural coronary artery (not a previously placed bypass graft)
- The blockage in that artery must be significant enough to warrant treatment, either blocking 70% or more of the artery, or 50–70% with additional evidence of reduced blood flow to the heart
- There must be at least one other artery with a blockage that also needs treatment
- That additional blockage must be suitable for a planned, non-urgent procedure within one month
Who may not be able to join:
- People showing signs of heart failure, including those with significantly reduced heart pumping function, or moderate-to-severe heart failure symptoms (confirm with trial site for specific classifications)
- People in cardiogenic shock (when the heart is suddenly unable to pump enough blood to meet the body's needs)
- People with known allergies or medical reasons to avoid aspirin, clopidogrel, ticagrelor, heparin, contrast dyes used during heart procedures, or materials used in drug-coated stents
- People whose life expectancy is less than 12 months, or who may have difficulty attending follow-up appointments
- People currently enrolled in another clinical drug or medical device trial that has not yet reached its main measurement point
- People with a history of substance misuse, such as alcohol, cocaine, or heroin
- People with serious heart rhythm problems (confirm with trial site for specific types)
- People with other medical conditions that the trial doctors consider make participation unsuitable
Based on heart artery images, people may also not be eligible if:
- The blockage is in the left main coronary artery (the main artery supplying the left side of the heart)
- The blockage is in a previously placed bypass graft
- There is a large blood clot visible in the artery being treated
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13701387189
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
OCT-Detected Neointimal Strut Coverage at 1-Month Post-Procedure
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.